Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,904.00    12.00 (0.63%)
Bid:
1,903.00
Ask:
1,905.00
Spread: 2.00 (0.105%)
Market Cap: £3.20b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Update on Catalyst Technologies sale

23 Feb 2026 07:00

RNS Number : 9927T
Johnson Matthey PLC
23 February 2026
 

23rd February 2026

 

Johnson Matthey Plc

(the Company)

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Transaction update

On 22nd May 2025, Johnson Matthey Plc ("JM") and Honeywell International, Inc. ("Honeywell") announced an agreement to sell JM's Catalyst Technologies business ("CT") to Honeywell (the "Transaction").

JM and Honeywell have agreed to extend the long stop date for satisfaction of the closing conditions (the "Long Stop Date") from 21st February to 21st July 2026. In the event that the only remaining antitrust approval condition is not satisfied by the Long Stop Date, the Long Stop Date may be further extended to 21st August 2026, if certain conditions are met. JM and Honeywell expect to complete the Transaction by the end of August 2026.

In agreeing to extend the Long Stop Date, JM and Honeywell have also agreed to amend the financial terms of the Transaction to reflect CT's business performance during 2025/26, which includes the deferral of key sustainable solutions licensing projects and reduced profitability from the supply of catalysts due to the challenging market environment. Accordingly, JM has agreed to sell the CT business to Honeywell for an enterprise value of £1,325 million on a cash and debt-free basis.

Consequently, JM now expects to return c.£1,000 million of net sale proceeds to its shareholders following completion of the Transaction, comprising £800 million through a special dividend with share consolidation, and £200 million through an on-market share buyback programme.

JM continues to make good progress on the implementation of its new cash-focused business model and is on track to deliver 2025/26 performance in line with guidance. This includes group underlying operating profit growth at the higher end of a mid single digit percentage range¹, and positive free cash flow that is materially higher than last year².

The person responsible for the release of this announcement is Simon Price, General Counsel and Company Secretary of JM.

ENDS

 

Enquiries: 

Investor Relations

 

 

Louise Curran

Head of Investor Relations

+44 20 7269 8235

Media

Sinead Keller

Guy Bates 

Group External Relations Director

Kekst CNC

+44 20 7269 8218

+44 7581 056 415

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

Notes:

1.

Underlying operating profit is on a pro forma basis excluding CT and Value Businesses, and at constant precious metal prices and constant currency. 

2.

Free cash flow defined as net cash flow from operating activities (excluding disposal related costs) after net interest paid, net purchases of non-current assets and investments and the principal elements of lease payments, adjusted to reflect the classification of Catalyst Technologies as a discontinued operation. 2024/25: £64 million inflow.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURXLLLLQLLEBBF
Date   Source Headline
13th Feb 20254:21 pmRNSDirector/PDMR Shareholding
13th Feb 202511:19 amRNSDirector/PDMR Shareholding
12th Feb 20257:00 amRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSBoard Changes
7th Feb 202510:15 amRNSDirector/PDMR Shareholding
6th Feb 20254:26 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSEstablishment of Investment Committee
27th Jan 20257:00 amRNSDelivering strategic objectives to drive value
23rd Jan 20254:47 pmRNSHolding(s) in Company
23rd Jan 20251:36 pmRNSDirector/PDMR Shareholding
22nd Jan 202510:13 amRNSHolding(s) in Company
15th Jan 20255:12 pmRNSHolding(s) in Company
8th Jan 20258:35 amRNSResponse to Letter from Standard Investments
7th Jan 20257:00 amRNSHolding(s) in Company
3rd Jan 20254:46 pmRNSHolding(s) in Company
31st Dec 20249:00 amRNSTotal Voting Rights
27th Dec 20248:07 amRNSHolding(s) in Company
23rd Dec 20244:21 pmRNSHolding(s) in Company
19th Dec 20243:10 pmRNSDirector/PDMR Shareholding
18th Dec 20243:17 pmRNSHolding(s) in Company
18th Dec 20243:08 pmRNSHolding(s) in Company
16th Dec 20244:36 pmRNSHolding(s) in Company
16th Dec 20244:06 pmRNSHolding(s) in Company
16th Dec 20241:13 pmRNSResponse to letter from Standard Investments
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20245:19 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTotal Voting Rights
9th Dec 20243:24 pmRNSHolding(s) in Company
9th Dec 20243:17 pmRNSHolding(s) in Company
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20243:33 pmRNSHolding(s) in Company
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20244:39 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20244:41 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20242:00 pmRNSTotal Voting Rights
29th Nov 20247:00 amRNSHolding(s) in Company
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20244:19 pmRNSDirector/PDMR Shareholding
28th Nov 20249:54 amRNSDirector/PDMR Shareholding
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20245:17 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSJohnson Matthey half year results
27th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.